CHERYL KIRBY: Open Payments
NPI 1285834705 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,747 in 85 payments from 24 companies in 2025. Trend: 2023 $1,399 · 2024 $1,423 · 2025 $1,747
Food & beverage: $1,747
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. | 7 | $172 |
| Abbott Laboratories | 10 | $156 |
| BETA BIONICS, INC. | 7 | $151 |
| Ascendis Pharma Endocrinology Inc | 7 | $145 |
| Madrigal Pharmaceuticals | 6 | $123 |
| RECORDATI_RARE_DISEASES_INC. | 5 | $102 |
| Dexcom, Inc. | 4 | $96 |
| Lilly USA, LLC | 4 | $90 |
| Xeris Pharmaceuticals, Inc. | 4 | $79 |
| Novo Nordisk Inc | 4 | $79 |
Products named: t:slim X2 Insulin Pump with Control-IQ, FREESTYLE LIBRE 3, iLet Bionic Pancreas, Yorvipath, REZDIFFRA, ISTURISA, Dexcom G6 Transmitter, MOUNJARO.
Industry payments across OK — which companies pay providers there.
